Skip to main content

Cramer: Real Opportunity in This Drug Maker

"It's speculative, but given their main drug has been approved and the stock's barely budged, I think we could have a real opportunity here," said Cramer
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.